News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,024 Results
Type
Article (47364)
Company Profile (296)
Press Release (680363)
Multimedia
Podcasts (79)
Webinars (15)
Section
Business (209505)
Career Advice (2216)
Deals (36079)
Drug Delivery (115)
Drug Development (82496)
Employer Resources (192)
FDA (16447)
Job Trends (15293)
News (353204)
Policy (33348)
Tag
Academia (2750)
Academic (2)
Accelerated approval (10)
Adcomms (25)
Allergies (97)
Alliances (51168)
ALS (113)
Alzheimer's disease (1494)
Antibody-drug conjugate (ADC) (158)
Approvals (16437)
Artificial intelligence (338)
Autoimmune disease (29)
Automation (19)
Bankruptcy (368)
Best Places to Work (11834)
BIOSECURE Act (20)
Biosimilars (125)
Biotechnology (199)
Bladder cancer (95)
Brain cancer (34)
Breast cancer (371)
Cancer (2924)
Cardiovascular disease (219)
Career advice (1862)
Career pathing (33)
CAR-T (196)
CDC (36)
Cell therapy (524)
Cervical cancer (23)
Clinical research (67654)
Collaboration (1057)
Company closure (3)
Compensation (691)
Complete response letters (25)
COVID-19 (2707)
CRISPR (60)
C-suite (340)
Cystic fibrosis (114)
Data (3037)
Decentralized trials (2)
Denatured (34)
Depression (64)
Diabetes (349)
Diagnostics (6582)
Digital health (23)
Diversity (10)
Diversity, equity & inclusion (48)
Drug discovery (144)
Drug pricing (131)
Drug shortages (29)
Duchenne muscular dystrophy (133)
Earnings (88384)
Editorial (43)
Employer branding (25)
Employer resources (163)
Events (117390)
Executive appointments (871)
FDA (18130)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (969)
Gene editing (137)
Generative AI (25)
Gene therapy (395)
GLP-1 (832)
Government (4664)
Grass and pollen (4)
Guidances (182)
Healthcare (19246)
HIV (41)
Huntington's disease (32)
IgA nephropathy (41)
Immunology and inflammation (155)
Immuno-oncology (9)
Indications (39)
Infectious disease (2883)
Inflammatory bowel disease (154)
Inflation Reduction Act (12)
Influenza (62)
Intellectual property (122)
Interviews (353)
IPO (16816)
IRA (47)
Job creations (3850)
Job search strategy (1588)
Kidney cancer (13)
Labor market (57)
Layoffs (518)
Leadership (22)
Legal (8092)
Liver cancer (80)
Longevity (11)
Lung cancer (411)
Lymphoma (210)
Machine learning (11)
Management (62)
Manufacturing (404)
MASH (93)
Medical device (13625)
Medtech (13630)
Mergers & acquisitions (19987)
Metabolic disorders (876)
Multiple sclerosis (99)
NASH (22)
Neurodegenerative disease (122)
Neuropsychiatric disorders (33)
Neuroscience (2194)
NextGen: Class of 2025 (6731)
Non-profit (4663)
Now hiring (49)
Obesity (448)
Opinion (237)
Ovarian cancer (103)
Pain (111)
Pancreatic cancer (123)
Parkinson's disease (190)
Partnered (22)
Patents (306)
Patient recruitment (169)
Peanut (52)
People (59746)
Pharmaceutical (71)
Pharmacy benefit managers (21)
Phase I (21080)
Phase II (29786)
Phase III (22173)
Pipeline (1655)
Policy (210)
Postmarket research (2643)
Preclinical (9205)
Press Release (72)
Prostate cancer (141)
Psychedelics (40)
Radiopharmaceuticals (260)
Rare diseases (473)
Real estate (6240)
Recruiting (73)
Regulatory (23110)
Reports (60)
Research institute (2484)
Resumes & cover letters (377)
Rett syndrome (9)
RNA editing (9)
RSV (51)
Schizophrenia (90)
Series A (167)
Series B (113)
Service/supplier (14)
Sickle cell disease (63)
Special edition (19)
Spinal muscular atrophy (151)
Sponsored (33)
Startups (3798)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (58)
The Weekly (43)
Vaccines (812)
Venture capital (56)
Weight loss (276)
Women's health (49)
Worklife (19)
Date
Today (91)
Last 7 days (371)
Last 30 days (1844)
Last 365 days (31654)
2025 (17219)
2024 (35960)
2023 (40874)
2022 (51944)
2021 (56525)
2020 (54924)
2019 (47700)
2018 (35970)
2017 (33118)
2016 (32693)
2015 (38795)
2014 (32402)
2013 (27579)
2012 (29834)
2011 (30561)
2010 (29073)
Location
Africa (800)
Alabama (63)
Alaska (7)
Arizona (253)
Arkansas (14)
Asia (39978)
Australia (6572)
California (7538)
Canada (2380)
China (682)
Colorado (330)
Connecticut (321)
Delaware (193)
Europe (86946)
Florida (1129)
Georgia (258)
Hawaii (2)
Idaho (60)
Illinois (658)
India (29)
Indiana (370)
Iowa (18)
Japan (232)
Kansas (111)
Kentucky (32)
Louisiana (15)
Maine (64)
Maryland (1041)
Massachusetts (5645)
Michigan (264)
Minnesota (472)
Mississippi (3)
Missouri (91)
Montana (28)
Nebraska (25)
Nevada (82)
New Hampshire (68)
New Jersey (2115)
New Mexico (30)
New York (2124)
North Carolina (1127)
North Dakota (10)
Northern California (3311)
Ohio (240)
Oklahoma (16)
Oregon (34)
Pennsylvania (1627)
Puerto Rico (17)
Rhode Island (36)
South America (1177)
South Carolina (34)
South Dakota (1)
Southern California (2817)
Tennessee (127)
Texas (1146)
United States (28111)
Utah (225)
Virginia (189)
Washington D.C. (77)
Washington State (642)
West Virginia (4)
Wisconsin (80)
728,024 Results for "sight sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sight Sciences Appoints Gary Burbach to its Board of Directors
April 23, 2025
·
7 min read
Press Releases
Sight Sciences to Present at the Stifel 2025 Virtual Ophthalmology Forum on May 27th
May 14, 2025
·
2 min read
Press Releases
Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025
April 25, 2025
·
2 min read
Press Releases
Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance
May 9, 2025
·
16 min read
Press Releases
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th
March 25, 2025
·
2 min read
Press Releases
Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio
April 22, 2025
·
8 min read
Press Releases
Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day
February 14, 2025
·
2 min read
Biotech Bay
Sight Sciences Announces the Release of its First Sustainability Report
Sight Sciences, Inc., an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced that it has published its first Sustainability Report, highlighting the Company’s sustainability activities, performance, and results from the last three years.
June 10, 2024
·
4 min read
Business
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
Sight Sciences, Inc. announced it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 2, 2024.
April 18, 2024
·
2 min read
Biotech Bay
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced it will present at the upcoming 23rd Annual Needham Healthcare Conference being held virtually.
March 26, 2024
·
2 min read
1 of 72,803
Next
